You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

3 Results
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    exemestane
Aug 2025
Regimen
Cancer Type:
Central Nervous System
Intent: Adjuvant
Funding:
ODB - General Benefit
    temozolomide
Aug 2025
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    letrozole
Aug 2025